IL108446A - Computer-based methods and articles of manufacture for preparing g-csf analogs - Google Patents
Computer-based methods and articles of manufacture for preparing g-csf analogsInfo
- Publication number
- IL108446A IL108446A IL10844694A IL10844694A IL108446A IL 108446 A IL108446 A IL 108446A IL 10844694 A IL10844694 A IL 10844694A IL 10844694 A IL10844694 A IL 10844694A IL 108446 A IL108446 A IL 108446A
- Authority
- IL
- Israel
- Prior art keywords
- analogs
- csf
- another aspect
- articles
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Heart & Thoracic Surgery (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL14599401A IL145994A0 (en) | 1993-01-28 | 2001-10-17 | An improvement in a computer-based apparatus for design of granulocyte colony stimulating factor (g-csf) analogs |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/010,099 US5581476A (en) | 1993-01-28 | 1993-01-28 | Computer-based methods and articles of manufacture for preparing G-CSF analogs |
Publications (2)
Publication Number | Publication Date |
---|---|
IL108446A0 IL108446A0 (en) | 1994-04-12 |
IL108446A true IL108446A (en) | 2003-01-12 |
Family
ID=21743861
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10844694A IL108446A (en) | 1993-01-28 | 1994-01-26 | Computer-based methods and articles of manufacture for preparing g-csf analogs |
IL145994A IL145994A (en) | 1993-01-28 | 1994-01-26 | Modified g-csf polypeptide wherein the modification comprises a chemical moiety attached in vitro to an external loop |
IL124112A IL124112A (en) | 1993-01-28 | 1994-01-26 | G-CSF analog molecules and their pharmaceutical compositions |
IL12411198A IL124111A (en) | 1993-01-28 | 1998-04-15 | Computer-based equipment for designing granulocyte-stimulating factor analogues (G-CSF) |
IL12539898A IL125398A0 (en) | 1993-01-28 | 1998-07-19 | G-csf analog compositions and methods |
IL14599401A IL145994A0 (en) | 1993-01-28 | 2001-10-17 | An improvement in a computer-based apparatus for design of granulocyte colony stimulating factor (g-csf) analogs |
Family Applications After (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL145994A IL145994A (en) | 1993-01-28 | 1994-01-26 | Modified g-csf polypeptide wherein the modification comprises a chemical moiety attached in vitro to an external loop |
IL124112A IL124112A (en) | 1993-01-28 | 1994-01-26 | G-CSF analog molecules and their pharmaceutical compositions |
IL12411198A IL124111A (en) | 1993-01-28 | 1998-04-15 | Computer-based equipment for designing granulocyte-stimulating factor analogues (G-CSF) |
IL12539898A IL125398A0 (en) | 1993-01-28 | 1998-07-19 | G-csf analog compositions and methods |
IL14599401A IL145994A0 (en) | 1993-01-28 | 2001-10-17 | An improvement in a computer-based apparatus for design of granulocyte colony stimulating factor (g-csf) analogs |
Country Status (22)
Country | Link |
---|---|
US (6) | US5581476A (xx) |
EP (8) | EP1482045A3 (xx) |
JP (7) | JPH08506018A (xx) |
KR (2) | KR100390338B1 (xx) |
CN (3) | CN1970571B (xx) |
AT (2) | ATE195552T1 (xx) |
AU (2) | AU697451B2 (xx) |
CA (4) | CA2153896C (xx) |
DE (1) | DE69425516T2 (xx) |
DK (3) | DK1482046T3 (xx) |
ES (3) | ES2422269T3 (xx) |
FI (2) | FI120769B (xx) |
GR (1) | GR3034745T3 (xx) |
HK (2) | HK1009288A1 (xx) |
IL (6) | IL108446A (xx) |
LU (1) | LU92265I2 (xx) |
LV (1) | LV12642B (xx) |
NO (3) | NO952974L (xx) |
NZ (5) | NZ314960A (xx) |
PT (3) | PT2345724E (xx) |
WO (1) | WO1994017185A1 (xx) |
ZA (1) | ZA94568B (xx) |
Families Citing this family (141)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE135370T1 (de) * | 1988-12-22 | 1996-03-15 | Kirin Amgen Inc | Chemisch modifizierte granulocytenkolonie erregender faktor |
US20020177688A1 (en) * | 1988-12-22 | 2002-11-28 | Kirin-Amgen, Inc., | Chemically-modified G-CSF |
US5581476A (en) * | 1993-01-28 | 1996-12-03 | Amgen Inc. | Computer-based methods and articles of manufacture for preparing G-CSF analogs |
US20030053982A1 (en) * | 1994-09-26 | 2003-03-20 | Kinstler Olaf B. | N-terminally chemically modified protein compositions and methods |
US5824784A (en) * | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
JP3708151B2 (ja) * | 1994-12-15 | 2005-10-19 | 協和醗酵工業株式会社 | Peg化したヒト顆粒球コロニー刺激因子の定量法 |
US20030185792A1 (en) * | 1996-01-22 | 2003-10-02 | Curis, Inc. | Morphogen analogs of bone morphogenic proteins |
AU725295B2 (en) * | 1996-01-22 | 2000-10-12 | Brandeis University | Morphogen analogs and methods for producing them |
US5835382A (en) | 1996-04-26 | 1998-11-10 | The Scripps Research Institute | Small molecule mimetics of erythropoietin |
US6128582A (en) | 1996-04-30 | 2000-10-03 | Vertex Pharmaceuticals Incorporated | Molecules comprising an IMPDH-like binding pocket and encoded data storage medium capable of graphically displaying them |
EP1012184B1 (en) * | 1997-07-14 | 2007-10-10 | Bolder Biotechnology, Inc. | Derivatives of growth hormone and related proteins |
US6753165B1 (en) | 1999-01-14 | 2004-06-22 | Bolder Biotechnology, Inc. | Methods for making proteins containing free cysteine residues |
US20080076706A1 (en) | 1997-07-14 | 2008-03-27 | Bolder Biotechnology, Inc. | Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof |
US6017876A (en) | 1997-08-15 | 2000-01-25 | Amgen Inc. | Chemical modification of granulocyte-colony stimulating factor (G-CSF) bioactivity |
CN1061992C (zh) * | 1997-11-19 | 2001-02-14 | 蒋永平 | 新的重组人粒细胞集落刺激因子及其药物组合物 |
CA2326755A1 (en) * | 1998-04-30 | 1999-11-04 | Tanox, Inc. | G-csf receptor agonist antibodies and screening method therefor |
TWI242563B (en) * | 1998-04-30 | 2005-11-01 | Tanox Inc | Monoclonal agonist antibodies which specifically bind to or interact with human G-CSF receptor |
US6541033B1 (en) | 1998-06-30 | 2003-04-01 | Amgen Inc. | Thermosensitive biodegradable hydrogels for sustained delivery of leptin |
US6979442B1 (en) | 1998-08-17 | 2005-12-27 | Pfizer Inc. | Stabilized protein compositions |
US6420339B1 (en) | 1998-10-14 | 2002-07-16 | Amgen Inc. | Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
US6451346B1 (en) * | 1998-12-23 | 2002-09-17 | Amgen Inc | Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents |
US7208473B2 (en) * | 1999-01-06 | 2007-04-24 | Xencor, Inc. | Nucleic acids and protein variants of hG-CSF with granulopoietic activity |
US6627186B1 (en) | 1999-01-06 | 2003-09-30 | Xencor | Nucleic acids and protein variants of hG-CSF with granulopoietic activity |
US8288126B2 (en) | 1999-01-14 | 2012-10-16 | Bolder Biotechnology, Inc. | Methods for making proteins containing free cysteine residues |
ATE246202T1 (de) * | 1999-01-29 | 2003-08-15 | Hoffmann La Roche | Gcsf konjugate |
US6500418B1 (en) * | 1999-02-12 | 2002-12-31 | The Washington University | Stimulating neutrophil function to treat inflammatory bowel disease |
JP2000319298A (ja) * | 1999-03-04 | 2000-11-21 | Seibutsu Bunshi Kogaku Kenkyusho:Kk | 蛋白質複合体の結晶、構造座標、及び構造座標の使用 |
US7247490B2 (en) | 1999-04-06 | 2007-07-24 | Uab Research Foundation | Method for screening crystallization conditions in solution crystal growth |
US7214540B2 (en) * | 1999-04-06 | 2007-05-08 | Uab Research Foundation | Method for screening crystallization conditions in solution crystal growth |
MXPA01009999A (es) * | 1999-04-06 | 2003-07-14 | Uab Research Foundation | Metodo para examinar las condiciones de cristalizacion en el crecimiento de cristales en solucion. |
US7250305B2 (en) | 2001-07-30 | 2007-07-31 | Uab Research Foundation | Use of dye to distinguish salt and protein crystals under microcrystallization conditions |
US7244396B2 (en) | 1999-04-06 | 2007-07-17 | Uab Research Foundation | Method for preparation of microarrays for screening of crystal growth conditions |
US20030022383A1 (en) * | 1999-04-06 | 2003-01-30 | Uab Research Foundation | Method for screening crystallization conditions in solution crystal growth |
WO2000068252A1 (en) * | 1999-05-10 | 2000-11-16 | The Regents Of The University Of California | Methods and compositions for controlled polypeptide synthesis |
US6296673B1 (en) * | 1999-06-18 | 2001-10-02 | The Regents Of The University Of California | Methods and apparatus for performing array microcrystallizations |
US6630006B2 (en) * | 1999-06-18 | 2003-10-07 | The Regents Of The University Of California | Method for screening microcrystallizations for crystal formation |
US7058517B1 (en) | 1999-06-25 | 2006-06-06 | Genaissance Pharmaceuticals, Inc. | Methods for obtaining and using haplotype data |
US7754855B1 (en) * | 1999-07-13 | 2010-07-13 | Bolder Biotechnology, Inc. | Immunoglobulin fusion proteins |
US8106098B2 (en) * | 1999-08-09 | 2012-01-31 | The General Hospital Corporation | Protein conjugates with a water-soluble biocompatible, biodegradable polymer |
ES2327606T3 (es) * | 2000-01-10 | 2009-11-02 | Maxygen Holdings Ltd | Conjugados de g-csf. |
US6646110B2 (en) * | 2000-01-10 | 2003-11-11 | Maxygen Holdings Ltd. | G-CSF polypeptides and conjugates |
US6555660B2 (en) * | 2000-01-10 | 2003-04-29 | Maxygen Holdings Ltd. | G-CSF conjugates |
US6831158B2 (en) * | 2000-01-10 | 2004-12-14 | Maxygen Holdings Ltd. | G-CSF conjugates |
GB0008563D0 (en) * | 2000-04-07 | 2000-05-24 | Cambridge Discovery Chemistry | Investigating different physical and/or chemical forms of materials |
ES2214240T3 (es) * | 2000-06-16 | 2004-09-16 | Vsi Holding A/S | Recipiente con costados plegables. |
US6931326B1 (en) | 2000-06-26 | 2005-08-16 | Genaissance Pharmaceuticals, Inc. | Methods for obtaining and using haplotype data |
US7792645B2 (en) * | 2000-08-30 | 2010-09-07 | The Salk Institute For Biological Studies | Three-dimensional structure of chalcone isomerase and methods of use thereof |
WO2002020751A2 (en) * | 2000-09-07 | 2002-03-14 | Eli Lilly And Company | Hyperglycosylated polypeptides |
WO2002020767A2 (en) * | 2000-09-08 | 2002-03-14 | Massachusetts Institute Of Technology | G-csf analog compositions and methods |
EP1334127A1 (en) * | 2000-11-02 | 2003-08-13 | Maxygen Aps | Single-chain multimeric polypeptides |
US20030032065A1 (en) * | 2001-03-12 | 2003-02-13 | Vince Hilser | Ensemble-based strategy for the design of protein pharmaceuticals |
DE10112825A1 (de) * | 2001-03-16 | 2002-10-02 | Fresenius Kabi De Gmbh | HESylierung von Wirkstoffen in wässriger Lösung |
US7670429B2 (en) | 2001-04-05 | 2010-03-02 | The California Institute Of Technology | High throughput screening of crystallization of materials |
US6998219B2 (en) * | 2001-06-27 | 2006-02-14 | University Of South Florida | Maskless photolithography for etching and deposition |
MXPA04000231A (es) * | 2001-07-11 | 2004-05-04 | Maxygen Holdings Ltd | Conjugados del factor de estimulacion de colonias de granulocitos. |
US20030104996A1 (en) * | 2001-08-30 | 2003-06-05 | Tiansheng Li | L-methionine as a stabilizer for NESP/EPO in HSA-free formulations |
US20040247562A1 (en) * | 2001-09-28 | 2004-12-09 | Sang Yup Lee | Diagnostic method for cancer characterized in the detection of the deletion of g-csf exon 3 |
DE10209821A1 (de) * | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung von Proteinen an ein modifiziertes Polysaccharid |
DE10209822A1 (de) | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid |
US20030191056A1 (en) | 2002-04-04 | 2003-10-09 | Kenneth Walker | Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins |
CA2487006A1 (en) * | 2002-05-23 | 2003-12-04 | Vince Hilser | Predicting the significance of single nucleotide polymorphisms (snps) using ensemble-based structural energetics |
WO2004005898A1 (en) * | 2002-07-10 | 2004-01-15 | Uab Research Foundation | Method for distinguishing between biomolecule and non-biomolecule crystals |
DE60332358D1 (de) * | 2002-09-09 | 2010-06-10 | Hanall Pharmaceutical Co Ltd | Protease-resistente modifizierte interferon alpha polypeptide |
DE10242076A1 (de) * | 2002-09-11 | 2004-03-25 | Fresenius Kabi Deutschland Gmbh | HAS-Allergen-Konjugate |
KR101045422B1 (ko) * | 2002-09-11 | 2011-06-30 | 프레제니우스 카비 도이치란트 게엠베하 | 하이드록시알킬 전분 유도체의 제조 방법 |
US9453251B2 (en) | 2002-10-08 | 2016-09-27 | Pfenex Inc. | Expression of mammalian proteins in Pseudomonas fluorescens |
ATE409048T1 (de) * | 2002-10-08 | 2008-10-15 | Fresenius Kabi De Gmbh | Pharmazeutisch aktive oligosaccharid-conjugate |
RS20050502A (xx) * | 2002-12-26 | 2007-08-03 | Mountain View Pharmaceuticals Inc., | Polimerni konjugati interferona- beta sa povećanom biološkom aktivnošću |
RS20050501A (xx) * | 2002-12-26 | 2007-08-03 | Mountain View Pharmaceuticals Inc., | Polimerni konjugati citokina,hemokina,faktora rasta, polipeptidnih hormona i njihovih antagonista sa očuvanom aktivnošću vezivanja receptora |
US7785601B2 (en) | 2002-12-31 | 2010-08-31 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
US7695723B2 (en) | 2002-12-31 | 2010-04-13 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
AU2004263274B2 (en) | 2003-07-21 | 2009-11-05 | Transgene S.A. | Novel multifunctional cytokines |
WO2005014655A2 (en) * | 2003-08-08 | 2005-02-17 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein |
US20080206182A1 (en) * | 2003-08-08 | 2008-08-28 | Fresenius Kabi Deutschland Gmbh | Conjugates of a Polymer and a Protein Linked by an Oxime Group |
US8338373B2 (en) * | 2003-10-24 | 2012-12-25 | Nora Therapeutics, Inc. | Method for reducing the risk of spontaneous abortion in a human female subject |
EP2198875A1 (en) | 2003-10-24 | 2010-06-23 | Nora, LLC | A method for reducing the likelihood of preterm labour in a subject in need thereof |
US20090226397A1 (en) * | 2003-10-24 | 2009-09-10 | Nora Therapeutics, Inc. | Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination |
US7220407B2 (en) * | 2003-10-27 | 2007-05-22 | Amgen Inc. | G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction |
US20060122784A1 (en) * | 2004-12-03 | 2006-06-08 | Ishikawa Muriel Y | System and method for augmenting a humoral immune response |
JP2007517042A (ja) | 2003-12-30 | 2007-06-28 | デュレクト コーポレーション | 活性物質、好ましくはgnrhの制御放出のための、好ましくはpegおよびplgの混合物を含有するポリマーインプラント |
EP1758608A2 (en) * | 2004-03-11 | 2007-03-07 | Fresenius Kabi Deutschland GmbH | Conjugates of hydroxyethyl starch and erythropoietin |
WO2005092928A1 (en) | 2004-03-11 | 2005-10-06 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination |
JP2008507294A (ja) | 2004-07-26 | 2008-03-13 | ダウ グローバル テクノロジーズ インコーポレイティド | 菌株遺伝子操作による改善されたタンパク質発現のための方法 |
WO2006055260A2 (en) * | 2004-11-05 | 2006-05-26 | Northwestern University | Use of scf and g-csf in the treatment of cerebral ischemia and neurological disorders |
WO2006063300A2 (en) * | 2004-12-10 | 2006-06-15 | Genentech, Inc. | Crystal structure of hepatocyte growth factor activator complexed with kunitz domain inhibitor |
EP1828241A1 (en) * | 2004-12-23 | 2007-09-05 | Laboratoires Serono S.A. | G-csf polypeptides and uses thereof |
ES2449195T3 (es) | 2005-01-10 | 2014-03-18 | Ratiopharm Gmbh | Factor estimulante de colonias de granulocitos glicopegilado |
KR100657749B1 (ko) * | 2005-04-13 | 2006-12-20 | 씨제이 주식회사 | 인간 과립구 콜로니 형성인자 동종체 및 그 조성물 |
CA2607844C (en) | 2005-06-01 | 2012-07-10 | Maxygen Holdings Ltd. | Pegylated g-csf polypeptides and methods of producing same |
KR100694994B1 (ko) * | 2005-06-13 | 2007-03-14 | 씨제이 주식회사 | 사람 과립구 콜로니 형성인자 동종체 |
KR100735784B1 (ko) | 2005-07-20 | 2007-07-06 | 재단법인 목암생명공학연구소 | 인간 과립구콜로니자극인자 변이체 및 이의 화학적 접합물 |
JP5509444B2 (ja) * | 2005-08-15 | 2014-06-04 | ファレス ファーマシューティカル リサーチ エヌ.ブイ. | アスタキサンチンの結晶形 |
US8017315B2 (en) * | 2005-08-22 | 2011-09-13 | Dana Farber Cancer Institute, Inc. | Mitochondrial localization of MUC1 |
US20070112804A1 (en) * | 2005-11-07 | 2007-05-17 | Desimas Bruce E | Systems and methods for generating automated software workflows for biological testing |
GB0605684D0 (en) * | 2006-03-21 | 2006-05-03 | Sicor Biotech Uab | Method For Purifying Granulocyte-Colony Stimulating Factor |
WO2008111996A2 (en) * | 2006-07-20 | 2008-09-18 | Dana-Farber Cancer Institute, Inc. | Muc1-ikb kinase complexes and their activities |
WO2008097844A2 (en) * | 2007-02-02 | 2008-08-14 | Dana -Farber Cancer Institute, Inc. | Methods and compositions relating to the regulation of apoptosis by muc1 and bh3- containing proapoptotic proteins |
US7972870B2 (en) | 2007-02-02 | 2011-07-05 | Dana-Farber Cancer Institute, Inc. | Methods and compositions relating to the regulation of MUC1 by HSF1 and STAT3 |
JP4375412B2 (ja) * | 2007-02-19 | 2009-12-02 | 株式会社デンソー | 蒸発器ユニット |
AU2008245696B2 (en) | 2007-04-27 | 2013-11-07 | Pelican Technology Holdings, Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
US9580719B2 (en) | 2007-04-27 | 2017-02-28 | Pfenex, Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
JP5244175B2 (ja) | 2007-07-03 | 2013-07-24 | アムジエン・インコーポレーテツド | 封入体乾燥重量を用いたタンパク質の測定 |
LT3597659T (lt) | 2007-07-09 | 2023-05-10 | Genentech, Inc. | Disulfidinės jungties redukcijos prevencijos būdas gaminant polipeptidą rekombinantiniu būdu |
EP2581441A1 (en) | 2007-08-09 | 2013-04-17 | Genzyme Corporation | Method of treating autoimmune disease with mesenchymal stem cells |
US8758761B2 (en) * | 2007-09-30 | 2014-06-24 | University Of Florida Research Foundation, Inc. | Combination therapies for treating type 1 diabetes |
US8570393B2 (en) * | 2007-11-30 | 2013-10-29 | Cognex Corporation | System and method for processing image data relative to a focus of attention within the overall image |
EP2070950A1 (en) * | 2007-12-14 | 2009-06-17 | Fresenius Kabi Deutschland GmbH | Hydroxyalkyl starch derivatives and process for their preparation |
EP2070951A1 (en) * | 2007-12-14 | 2009-06-17 | Fresenius Kabi Deutschland GmbH | Method for producing a hydroxyalkyl starch derivatives with two linkers |
EP3103880A1 (en) | 2008-02-08 | 2016-12-14 | Ambrx, Inc. | Modified leptin polypeptides and their uses |
EP2248832B1 (en) | 2008-02-18 | 2014-09-03 | Jiangsu Hengrui Medicine Co., Ltd. | A g-csf conjugate modified by water-soluble polymer |
JOP20190083A1 (ar) | 2008-06-04 | 2017-06-16 | Amgen Inc | بولي ببتيدات اندماجية طافرة لـfgf21 واستخداماتها |
CN102223893B (zh) | 2008-07-22 | 2014-07-16 | 曼诺吉尼克斯公司 | 治疗与绝经、激素改变和关节炎相关的症状的组合物和方法 |
UA118536C2 (uk) * | 2008-07-23 | 2019-02-11 | Амбркс, Інк. | Модифікований поліпептид бичачого гранулоцитарного колонієстимулювального фактора та його застосування |
US9151289B2 (en) | 2008-08-21 | 2015-10-06 | Cummins Inc. | Fuel pump |
EP2358749B1 (en) | 2008-10-10 | 2018-07-18 | Amgen, Inc | Fgf21 mutants and uses thereof |
NZ592537A (en) | 2008-10-17 | 2012-07-27 | Dana Farber Cancer Inst Inc | Muc-1 cytoplasmic domain peptides as inhibitors of cancer |
US9189670B2 (en) * | 2009-02-11 | 2015-11-17 | Cognex Corporation | System and method for capturing and detecting symbology features and parameters |
DK3248610T3 (da) * | 2009-05-05 | 2024-01-15 | Amgen Inc | Fgf21-mutanter og anvendelser deraf |
AU2010246038A1 (en) | 2009-05-05 | 2011-12-01 | Amgen Inc. | FGF21 mutants and uses thereof |
EP2443145A1 (en) * | 2009-06-17 | 2012-04-25 | Amgen, Inc | Chimeric fgf19 polypeptides and uses thereof |
AU2010326024A1 (en) | 2009-12-02 | 2012-07-05 | Amgen Inc. | Binding proteins that bind to human FGFR1c, human beta-Klotho and both human FGFR1c and human beta-Klotho |
UA109888C2 (uk) | 2009-12-07 | 2015-10-26 | ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ | |
CN102753573A (zh) | 2009-12-21 | 2012-10-24 | Ambrx公司 | 经过修饰的牛促生长素多肽和其用途 |
NZ600363A (en) | 2009-12-21 | 2014-07-25 | Ambrx Inc | Modified porcine somatotropin polypeptides and their uses |
EP2548017A2 (en) | 2010-03-15 | 2013-01-23 | Genus Oncology, Llc | Small molecule inhibitors of muc1 and methods of identifying the same |
WO2011117259A1 (en) | 2010-03-23 | 2011-09-29 | Imba - Institut Für Molekulare Biotechnologie Gmbh | Methods for identifying inhibitors of the type iii secretion system |
EP2558497A2 (en) | 2010-04-15 | 2013-02-20 | Amgen Inc. | Human fgf receptor and beta-klotho binding proteins |
TWI480288B (zh) | 2010-09-23 | 2015-04-11 | Lilly Co Eli | 牛顆粒細胞群落刺激因子及其變體之調配物 |
PT2621519T (pt) | 2010-09-28 | 2017-10-04 | Aegerion Pharmaceuticals Inc | Polipéptido de fusão de leptina-abd com duração de ação melhorada |
US8889630B2 (en) | 2011-12-23 | 2014-11-18 | Carlos Lopez | Method for hair regrowth using Granulocyte-Colony Stimulating Factor |
EP2897633B1 (en) | 2012-09-18 | 2020-01-01 | UTI Limited Partnership | Treatment of pain by inhibition of usp5 de-ubiquitinase |
CN105008397B (zh) | 2013-03-15 | 2021-07-06 | 勇士生物科学公司 | 作为治疗试剂的Gla结构域 |
LT6161B (lt) | 2013-09-27 | 2015-06-25 | Uab Profarma | Granuliocitų kolonijas stimuliuojančio faktoriaus sulieti baltymai su kitais augimo faktoriais, optimaliai su kamieninių ląstelių faktoriumi, ir jų gavimo būdas |
WO2015057724A1 (en) | 2013-10-14 | 2015-04-23 | Nora Therapeutics, Inc. | Use of g-csf for treating or preventing villitis of unknown etiology in a human female |
US20160361426A1 (en) * | 2015-06-11 | 2016-12-15 | Prolong Pharmaceuticals, LLC | Pegylated granulocyte colony stimulating factor (gcsf) |
WO2017067958A1 (en) * | 2015-10-19 | 2017-04-27 | Sandoz Ag | Improved coding sequence for human g-csf |
PE20201462A1 (es) | 2017-09-05 | 2020-12-17 | Gladiator Biosciences Inc | Metodo de direccionamiento de exosomas |
CN108384747A (zh) * | 2018-03-05 | 2018-08-10 | 安徽省农业科学院园艺研究所 | 表达狂犬抗体的cho细胞无血清悬浮培养方法 |
CN114901684A (zh) * | 2019-10-08 | 2022-08-12 | 酵活有限公司 | 粒细胞集落刺激因子受体(g-csfr)的经修饰胞外结构域和结合其的细胞因子 |
US20230227520A1 (en) | 2019-12-17 | 2023-07-20 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Novel g-csf mimics and their applications |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
WO1985000817A1 (en) * | 1983-08-10 | 1985-02-28 | Amgen | Microbial expression of interleukin ii |
US4810643A (en) * | 1985-08-23 | 1989-03-07 | Kirin- Amgen Inc. | Production of pluripotent granulocyte colony-stimulating factor |
JPS6263335A (ja) * | 1985-09-13 | 1987-03-20 | Fuji Photo Film Co Ltd | 化学反応情報の処理方法 |
US4908773A (en) * | 1987-04-06 | 1990-03-13 | Genex Corporation | Computer designed stabilized proteins and method for producing same |
DK203187A (da) * | 1986-04-22 | 1987-10-23 | Immunex Corp | Human g-csf proteinekspression |
WO1988001297A1 (en) * | 1986-08-11 | 1988-02-25 | Cetus Corporation | Expression of g-csf and muteins thereof |
US4704692A (en) * | 1986-09-02 | 1987-11-03 | Ladner Robert C | Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides |
DK174044B1 (da) * | 1986-12-23 | 2002-05-06 | Kyowa Hakko Kogyo Kk | Polypeptid afledt fra human granulocytkolonistimulerende faktor, og fremgangsmåde til fremstilling deraf, DNA kodende for nævnte polypeptid, rekombinant plasmid indeholdende nævnte DNA, og mikroorganismer indeholdende nævnte rekombinante plasmid....... |
US4853871A (en) * | 1987-04-06 | 1989-08-01 | Genex Corporation | Computer-based method for designing stablized proteins |
US4904584A (en) * | 1987-12-23 | 1990-02-27 | Genetics Institute, Inc. | Site-specific homogeneous modification of polypeptides |
GB2213821B (en) * | 1987-12-23 | 1992-01-02 | British Bio Technology | Synthetic human granulocyte colony stimulating factor gene |
US5153265A (en) * | 1988-01-20 | 1992-10-06 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
CA1340810C (en) * | 1988-03-31 | 1999-11-02 | Motoo Yamasaki | Polypeptide derivatives of human granulocyte colony stimulating factor |
ATE111921T1 (de) * | 1988-06-03 | 1994-10-15 | Chugai Pharmaceutical Co Ltd | Menschlicher kristallinischer granulocyt- koloniestimulierungsfaktor und dessen herstellung. |
US5025388A (en) * | 1988-08-26 | 1991-06-18 | Cramer Richard D Iii | Comparative molecular field analysis (CoMFA) |
US5218092A (en) * | 1988-09-29 | 1993-06-08 | Kyowa Hakko Kogyo Co., Ltd. | Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains |
US5166322A (en) * | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
US5109119A (en) * | 1989-06-06 | 1992-04-28 | Schering Corporation | Crystalline r-h-gm-csf and method |
US5265030A (en) * | 1990-04-24 | 1993-11-23 | Scripps Clinic And Research Foundation | System and method for determining three-dimensional structures of proteins |
GB9107846D0 (en) | 1990-04-30 | 1991-05-29 | Ici Plc | Polypeptides |
DE4014750A1 (de) | 1990-05-08 | 1991-11-14 | Boehringer Mannheim Gmbh | Muteine des granulozyten-stimulierenden faktors (g-csf) |
JP3249147B2 (ja) | 1990-06-01 | 2002-01-21 | キリン−アムジエン・インコーポレーテツド | 生理活性蛋白含有経口製剤 |
IE912365A1 (en) | 1990-07-23 | 1992-01-29 | Zeneca Ltd | Continuous release pharmaceutical compositions |
AU651152B2 (en) | 1990-08-29 | 1994-07-14 | Genetics Institute, Llc | Multidomain hematopoiesis stimulators |
US5124297A (en) | 1990-12-07 | 1992-06-23 | Amoco Corporation | Olefin polymerization and copolymerization catalyst |
DE4105480A1 (de) | 1991-02-21 | 1992-08-27 | Boehringer Mannheim Gmbh | Verbesserte aktivierung von rekombinanten proteinen |
JPH06506217A (ja) * | 1991-03-18 | 1994-07-14 | エンゾン,インコーポレーテッド | ポリペプチドまたはグリコポリペプチドとポリマーとのヒドラジン含有結合体 |
US5157736A (en) * | 1991-04-19 | 1992-10-20 | International Business Machines Corporation | Apparatus and method for optical recognition of chemical graphics |
US5386507A (en) * | 1991-07-18 | 1995-01-31 | Teig; Steven L. | Computer graphics system for selectively modelling molecules and investigating the chemical and physical properties thereof |
CA2116533A1 (en) * | 1991-08-30 | 1993-03-18 | George J. Todaro | Hybrid cytokines |
JP2638359B2 (ja) * | 1991-11-26 | 1997-08-06 | 富士通株式会社 | 分子動力学法の拘束条件作成装置 |
EP0955365A3 (en) * | 1992-06-09 | 2000-12-20 | Chiron Corporation | Crystallization of M-CSF |
US6057133A (en) | 1992-11-24 | 2000-05-02 | G. D. Searle | Multivariant human IL-3 fusion proteins and their recombinant production |
US5738849A (en) | 1992-11-24 | 1998-04-14 | G. D. Searle & Co. | Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them |
US6153183A (en) | 1992-11-24 | 2000-11-28 | G. D. Searle & Company | Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production |
US5772992A (en) | 1992-11-24 | 1998-06-30 | G.D. Searle & Co. | Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors |
WO1994012639A2 (en) | 1992-11-24 | 1994-06-09 | G. D. Searle & Co. | Interleukin-3 (il-3) mutant polypeptides |
US5424963A (en) * | 1992-11-25 | 1995-06-13 | Photon Research Associates, Inc. | Molecular dynamics simulation method and apparatus |
US5581476A (en) * | 1993-01-28 | 1996-12-03 | Amgen Inc. | Computer-based methods and articles of manufacture for preparing G-CSF analogs |
US5635599A (en) | 1994-04-08 | 1997-06-03 | The United States Of America As Represented By The Department Of Health And Human Services | Fusion proteins comprising circularly permuted ligands |
US5824784A (en) * | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
JPH11500308A (ja) | 1995-02-03 | 1999-01-12 | ジー.ディー.サール アンド カンパニー | 新規c−MPLリガンド |
US6017523A (en) | 1995-06-06 | 2000-01-25 | G.D. Searle & Co. | Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides |
AU717733B2 (en) | 1995-10-05 | 2000-03-30 | G.D. Searle & Co. | Novel G-CSF receptor agonists |
US6100070A (en) | 1995-10-05 | 2000-08-08 | G. D. Searle & Co. | G-CSF receptor agonists |
US6066318A (en) | 1995-10-05 | 2000-05-23 | G.D. Searle & Co. | Multi-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factors |
JP2000513924A (ja) | 1995-10-05 | 2000-10-24 | ジー.ディー.サール アンド カンパニー | 新規c−mpl受容体アゴニスト |
CZ295518B6 (cs) | 1995-10-05 | 2005-08-17 | G. D. Searle & Co. | Multifunkční agonisté hematopoetických receptorů |
US5969105A (en) | 1996-10-25 | 1999-10-19 | Feng; Yiqing | Stem cell factor receptor agonists |
US6660257B1 (en) | 1996-10-25 | 2003-12-09 | Pharmacia Corporation | Circular permuteins of flt3 ligand |
KR100497423B1 (ko) | 1996-10-25 | 2005-07-07 | 지.디. 썰 엘엘씨 | 다기능 키메라 조혈 수용체 아고니스트 |
BR9808514A (pt) | 1997-04-11 | 2000-05-23 | Searle & Co | Proteìnas quiméricas do ligante flt3 |
AU6246599A (en) | 1998-09-25 | 2000-04-17 | G.D. Searle & Co. | Method of producing permuteins by scanning permutagenesis |
US6555660B2 (en) * | 2000-01-10 | 2003-04-29 | Maxygen Holdings Ltd. | G-CSF conjugates |
EP2279755B1 (en) * | 2001-10-10 | 2014-02-26 | ratiopharm GmbH | Remodelling and glycoconjugation of Fibroblast Growth Factor (FGF) |
-
1993
- 1993-01-28 US US08/010,099 patent/US5581476A/en not_active Expired - Lifetime
-
1994
- 1994-01-25 CN CN2006101014030A patent/CN1970571B/zh not_active Expired - Lifetime
- 1994-01-25 CA CA002153896A patent/CA2153896C/en not_active Expired - Lifetime
- 1994-01-25 CA CA2711007A patent/CA2711007C/en not_active Expired - Lifetime
- 1994-01-25 KR KR10-2001-7006530A patent/KR100390338B1/ko not_active IP Right Cessation
- 1994-01-25 NZ NZ314960A patent/NZ314960A/xx not_active IP Right Cessation
- 1994-01-25 NZ NZ513422A patent/NZ513422A/xx not_active IP Right Cessation
- 1994-01-25 WO PCT/US1994/000913 patent/WO1994017185A1/en active Application Filing
- 1994-01-25 KR KR1019950703096A patent/KR100375274B1/ko not_active IP Right Cessation
- 1994-01-25 NZ NZ332188A patent/NZ332188A/xx not_active IP Right Cessation
- 1994-01-25 NZ NZ261765A patent/NZ261765A/en not_active IP Right Cessation
- 1994-01-25 CN CN03145268XA patent/CN1495197B/zh not_active Expired - Lifetime
- 1994-01-25 CA CA2381489A patent/CA2381489C/en not_active Expired - Lifetime
- 1994-01-25 JP JP6517294A patent/JPH08506018A/ja not_active Withdrawn
- 1994-01-25 AU AU60957/94A patent/AU697451B2/en not_active Expired
- 1994-01-25 CA CA002239360A patent/CA2239360C/en not_active Expired - Lifetime
- 1994-01-25 CN CN94191031A patent/CN1118572C/zh not_active Expired - Lifetime
- 1994-01-26 IL IL10844694A patent/IL108446A/xx not_active IP Right Cessation
- 1994-01-26 IL IL145994A patent/IL145994A/en not_active IP Right Cessation
- 1994-01-26 IL IL124112A patent/IL124112A/en not_active IP Right Cessation
- 1994-01-27 EP EP04019073A patent/EP1482045A3/en not_active Withdrawn
- 1994-01-27 EP EP01128744A patent/EP1233065A1/en not_active Withdrawn
- 1994-01-27 EP EP98113221A patent/EP0890640A3/en not_active Withdrawn
- 1994-01-27 EP EP04019074A patent/EP1482046B1/en not_active Expired - Lifetime
- 1994-01-27 EP EP94101207A patent/EP0612846B1/en not_active Expired - Lifetime
- 1994-01-27 EP EP99113571A patent/EP0974655A3/en not_active Withdrawn
- 1994-01-27 ZA ZA94568A patent/ZA94568B/xx unknown
- 1994-01-27 ES ES10011853T patent/ES2422269T3/es not_active Expired - Lifetime
- 1994-01-27 EP EP99112115A patent/EP0965638A3/en not_active Withdrawn
- 1994-01-27 DE DE69425516T patent/DE69425516T2/de not_active Expired - Lifetime
- 1994-01-27 DK DK04019074.6T patent/DK1482046T3/da active
- 1994-01-27 PT PT100118538T patent/PT2345724E/pt unknown
- 1994-01-27 ES ES04019074T patent/ES2382927T3/es not_active Expired - Lifetime
- 1994-01-27 DK DK94101207T patent/DK0612846T3/da active
- 1994-01-27 AT AT94101207T patent/ATE195552T1/de active
- 1994-01-27 AT AT04019074T patent/ATE553199T1/de active
- 1994-01-27 ES ES94101207T patent/ES2150951T3/es not_active Expired - Lifetime
- 1994-01-27 PT PT04019074T patent/PT1482046E/pt unknown
- 1994-01-27 EP EP10011853.8A patent/EP2345724B1/en not_active Revoked
- 1994-01-27 DK DK10011853.8T patent/DK2345724T3/da active
- 1994-01-27 PT PT94101207T patent/PT612846E/pt unknown
-
1995
- 1995-05-24 US US08/448,716 patent/US5790421A/en not_active Expired - Lifetime
- 1995-07-27 FI FI953593A patent/FI120769B/fi not_active IP Right Cessation
- 1995-07-27 NO NO952974A patent/NO952974L/no not_active Application Discontinuation
-
1998
- 1998-04-15 IL IL12411198A patent/IL124111A/en not_active IP Right Cessation
- 1998-07-19 IL IL12539898A patent/IL125398A0/xx not_active IP Right Cessation
- 1998-07-31 HK HK98109568A patent/HK1009288A1/xx not_active IP Right Cessation
- 1998-08-28 AU AU81970/98A patent/AU8197098A/en not_active Abandoned
-
1999
- 1999-05-03 US US09/304,186 patent/US6261550B1/en not_active Expired - Lifetime
-
2000
- 2000-05-30 NZ NZ504840A patent/NZ504840A/en not_active IP Right Cessation
- 2000-11-02 GR GR20000402433T patent/GR3034745T3/el unknown
- 2000-11-23 LV LV000158A patent/LV12642B/en unknown
-
2001
- 2001-01-03 US US09/754,532 patent/US6632426B2/en not_active Expired - Fee Related
- 2001-10-17 IL IL14599401A patent/IL145994A0/xx unknown
- 2001-12-20 US US10/032,108 patent/US7381804B2/en not_active Expired - Fee Related
-
2003
- 2003-04-02 NO NO20031497A patent/NO20031497D0/no unknown
- 2003-09-25 JP JP2003333761A patent/JP2004113243A/ja not_active Withdrawn
-
2005
- 2005-04-25 US US11/113,581 patent/US8058398B2/en not_active Expired - Fee Related
- 2005-11-17 JP JP2005333253A patent/JP2006096762A/ja not_active Withdrawn
- 2005-11-17 JP JP2005333254A patent/JP2006137762A/ja not_active Withdrawn
-
2007
- 2007-11-27 HK HK07112941.8A patent/HK1107356A1/xx unknown
-
2008
- 2008-07-15 JP JP2008183538A patent/JP2009057368A/ja not_active Withdrawn
-
2009
- 2009-10-21 FI FI20090384A patent/FI123078B/fi not_active IP Right Cessation
- 2009-10-30 JP JP2009249964A patent/JP2010059170A/ja active Pending
- 2009-12-08 NO NO20093489A patent/NO20093489L/no not_active Application Discontinuation
-
2011
- 2011-04-11 JP JP2011087129A patent/JP2011207885A/ja not_active Withdrawn
-
2013
- 2013-08-12 LU LU92265C patent/LU92265I2/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL108446A (en) | Computer-based methods and articles of manufacture for preparing g-csf analogs | |
FR2681786B1 (xx) | ||
IL73785A (en) | Dna sequences encoding for human erythropoietin,vectors including it,host cells transformed by them,process for producing human erythropoietin and pharmaceutical compositions comprising it | |
AU596997C (en) | Pharmaceutical composition for the treatment of leukopenia | |
DK12990A (da) | Human granulocyt-makrofag-kolonistimulerende faktor og muteiner heraf | |
IL139335A (en) | Mpl ligand polypeptides, nucleic acids encoding them, vectors and host cells comprising such nucleic acids, processes for producing such polypeptides pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating thrombocytopenia | |
AU7726287A (en) | Process for the preparation of compounds comprising triazole or imidazole and tetrahydrofuran groups and new compounds used in the process | |
Bassendowska-Karska et al. | Effect of formaldehyde on sister chromatid exchanges. | |
ZA844989B (en) | Proteins,pharmaceutical compositions,genes,vectors,host organisms and processes for their production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |